|A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines||
||2743||All||55 Years and older (Adult, Senior)||NCT00232180||A6141079||EMPHASIS-HF||March 2006||May 2010||January 2012||October 4, 2005||April 22, 2013||June 27, 2011||
|2||NCT02344199||Completed||Eplerenone in Heart Failure Treatment||
||450||All||18 Years to 90 Years (Adult, Senior)||NCT02344199||2015-PLR-EL-55||INOSET||March 2015||April 2016||April 2016||January 22, 2015||May 18, 2016||
† Study has passed its completion date and status has not been verified in more than two years.